News Opinion Editor's Corner TCT 2017 My Takeaways From TCT 2017: Show Up, Keep It Civil, and Bring Your Best Self Shelley Wood November 22, 2017
News Conference News TCT 2017 Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock Yael L. Maxwell November 09, 2017
News Conference News TCT 2017 Intermediate-Risk TAVR Substantially More Cost-effective Than Surgery Yael L. Maxwell October 31, 2017
News Conference News TCT 2017 TCT 2017: High Hopes in Denver for Complex PCI, Shorter DAPT Durations, TAVR Costs, and More Shelley Wood October 20, 2017
News Daily News FDA Expands CoreValve Indication to Include Intermediate-Risk Patients Michael O'Riordan July 10, 2017
News Conference News TVT 2017 Valve Leaflet Thrombosis: Treat It or Leave It Be? Shelley Wood June 19, 2017
News Conference News TVT 2017 Lagging Behind: Guidelines Can’t Keep Up With Growing TAVR Evidence Base Michael O'Riordan June 17, 2017
News Daily News FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement Michael O'Riordan June 06, 2017
News Daily News Conscious Sedation in TAVR Cuts Costs by 25%, Boosts Patient Satisfaction Shelley Wood April 13, 2017